NAVIDEA BIOPHARMACEUTICALS, INC. Annual Operating Lease, Payments in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Navidea Biopharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2022.
  • Navidea Biopharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $9.44K, a 89.9% decline year-over-year.
  • Navidea Biopharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $291K, a 15.4% decline from 2021.
  • Navidea Biopharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $344K, a 1.55% increase from 2020.
  • Navidea Biopharmaceuticals, Inc. annual Operating Lease, Payments for 2020 was $339K, a 2.73% increase from 2019.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $291K -$53.2K -15.4% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-27
2021 $344K +$5.27K +1.55% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $339K +$9K +2.73% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $330K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.